Liu Z - Search Results

1

Hyperactive Follicular Helper T Cells Contribute to Dysregulated Humoral Immunity in Patients With Liver Cirrhosis.

Zhao J, Shi J, Qu M, Zhao X, Wang H, Huang M, Liu Z, Li Z, He Q, Zhang S, Zhang Z. Zhao J, et al. Among authors: liu z. Front Immunol. 2019 Aug 13;10:1915. doi: 10.3389/fimmu.2019.01915. eCollection 2019. Front Immunol. 2019. PMID: 31456809 Free PMC article.

2

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS. Fu J, et al. Among authors: liu z. Gastroenterology. 2007 Jun;132(7):2328-39. doi: 10.1053/j.gastro.2007.03.102. Epub 2007 Apr 14. Gastroenterology. 2007. PMID: 17570208

3

[Primry research of separation and culture of adult hepatocytes].

Liu HL, Xin SJ, You SL, Hu Y, Rong YH, Zhou L, Yang YP, Li ZW, Liu ZW, Mao PY. Liu HL, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Oct;22(5):376-8. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008. PMID: 19469180 Chinese.

4

Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.

Wang Z, Tang X, Zhang Y, Qi R, Li Z, Zhang K, Liu Z, Yang X. Wang Z, et al. Among authors: liu z. Biomed Pharmacother. 2012 Apr;66(3):161-6. doi: 10.1016/j.biopha.2011.09.008. Epub 2011 Dec 29. Biomed Pharmacother. 2012. PMID: 22425181

5

Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.

Fu J, Zhang Z, Zhou L, Qi Z, Xing S, Lv J, Shi J, Fu B, Liu Z, Zhang JY, Jin L, Zhao Y, Lau GK, Zhao J, Wang FS. Fu J, et al. Among authors: liu z. Hepatology. 2013 Jul;58(1):139-49. doi: 10.1002/hep.26054. Epub 2013 Feb 15. Hepatology. 2013. PMID: 22961630

6

Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients.

Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, Zhang A, Shi J, Chen L, Lv S, He W, Geng H, Jin L, Liu Z, Wang FS. Shi M, et al. Among authors: liu z. Stem Cells Transl Med. 2012 Oct;1(10):725-31. doi: 10.5966/sctm.2012-0034. Epub 2012 Oct 11. Stem Cells Transl Med. 2012. PMID: 23197664 Free PMC article. Clinical Trial.

7

Characteristics of Vδ1(+) and Vδ2(+) γδ T cell subsets in acute liver allograft rejection.

Yu X, Liu Z, Wang Y, Wang H, Zhang M, Sun Y, Su H, Jin L, Wang F, Shi M. Yu X, et al. Among authors: liu z. Transpl Immunol. 2013 Dec;29(1-4):118-22. doi: 10.1016/j.trim.2013.09.001. Epub 2013 Sep 10. Transpl Immunol. 2013. PMID: 24029467 Clinical Trial.

8

Targeting the raft-associated Akt signaling in hepatocellular carcinoma.

Liu Y, Lv JY, Shi JF, Yang M, Liu SH, Li ZW, Wang HB, Zhang SG, Liu ZW, Ding JB, Xu DP, Zhao JM. Liu Y, et al. Biomed Res Int. 2014;2014:836025. doi: 10.1155/2014/836025. Epub 2014 Aug 27. Biomed Res Int. 2014. PMID: 25243186 Free PMC article.

9

The ratio of circulating regulatory T cells (Tregs)/Th17 cells is associated with acute allograft rejection in liver transplantation.

Wang Y, Zhang M, Liu ZW, Ren WG, Shi YC, Sun YL, Wang HB, Jin L, Wang FS, Shi M. Wang Y, et al. PLoS One. 2014 Nov 5;9(11):e112135. doi: 10.1371/journal.pone.0112135. eCollection 2014. PLoS One. 2014. PMID: 25372875 Free PMC article. Retracted. Clinical Trial.

10

A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection.

Shi M, Liu Z, Wang Y, Xu R, Sun Y, Zhang M, Yu X, Wang H, Meng L, Su H, Jin L, Wang FS. Shi M, et al. Among authors: liu z. Stem Cells Transl Med. 2017 Dec;6(12):2053-2061. doi: 10.1002/sctm.17-0134. Stem Cells Transl Med. 2017. PMID: 29178564 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83,194 results

Search Page